MedPath

ChoCar trial; The role of gut microbiota in choline and carnitine metabolism on vascular inflammation in metabolic syndrome

Completed
Conditions
Atherosclerosis
vessel calcification
10011082
10003216
Registration Number
NL-OMON39717
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Subjects: Kaukasian, adult, obese males with BMI >30 kg/m2 and metabolic syndrome, including increased fasting glucose
Donors: healthy, adult, lean males (BMI 20-25 kg/m2) on a vegetarian diet

Exclusion Criteria

Supplement use (including vitamin/choline/carnitine supplements, energy drinks and carnitine-enriched soymilk); a medical history of a cardiovascular event (myocardial infarction or stroke) or cholecystectomy; use of medication including antacids and oral antibiotics in the past three months; (expected) prolonged compromised immunity (e.g. due to recent cytotoxic chemotherapy or HIV-infection with a CD4 count < 240).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary endpoint concerns changes in postprandial choline and carnitine<br /><br>metabolism at baseline and 2 weeks after vegetarian microbial transplantation.<br /><br>We hypothesize that post-treatment changes are caused by altered gut microbiota<br /><br>composition. Thus fecal samples will be obtained for relating these changes.<br /><br><br /><br>Changes in gut microbiota composition<br /><br>Morning stool samples will be collected at baseline, 1 and 2 weeks after start<br /><br>of the study to determine microbiota composition upon vegetarian microbial<br /><br>transplantation. Samples will be taken by collection on toilet paper or in a<br /><br>fecal container, to be directly frozen at -80 degrees C in the AMC. Fecal<br /><br>analysis will be done by HITChip array which is developed for exact and<br /><br>sensitive enumeration of bacterial population</p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath